ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2376

Systemic Lupus Erythematosus Patients Exhibit Dynamic Changes in Disease-Associated Transcripts Following Total Knee or Total Hip Arthroplasty

David Fernandez1, Stephen Batter1, Deanna Jannat-Khah1, Mikhail Olferiev1, Insa Mannstadt2, Mark Figgie1, Peter Sculco1, Jason Blevins1, Caroline Siegel1, Dina Greenman1, Kyriakos Kirou1 and Susan Goodman3, 1Hospital for Special Surgery, New York, NY, 2Columbia University VP&S, New York, NY, 3Hospital for Special Surgery, New York 10025, NY

Meeting: ACR Convergence 2024

Keywords: Arthroplasty, interferon, surgery, Systemic lupus erythematosus (SLE), Total joint replacement

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with systemic lupus erythematosus (SLE) undergoing total hip arthroplasty and total knee arthroplasty (THA and TKA) experience higher complication rates than osteoarthritis (OA) patients.

There are several molecular processes in SLE patients that may affect the response to the physiologic stresses of arthroplasty. Excess Type 1 interferon (IFN) is a critical driver of SLE pathogenesis, and it may affect the response to surgery as well as the postoperative healing process. However, other pathways associated with negative postoperative outcomes have not been identified.

Methods: This prospective study enrolled 30 SLE patients with SLE satisfying 2019 ACR/EULAR or the 1997 modification of 1982 ACR SLE classification criteria, and 26 age/sex/procedure-matched OA controls who were undergoing THA/TKA.  SLE-specific disease activity was evaluated by a rheumatologist (D.R.F., C.S.) on postoperative day 1 (POD1). Standard laboratory tests, as well as plasma and whole blood samples were collected from subjects at baseline, POD1, and six weeks postoperatively (6W). Whole blood RNA sequencing was performed from a subset of samples obtained at baseline, POD1, and 6W. Adverse events were assessed at baseline, 1-, 6-, 12-, and 24-weeks. Descriptive statistics were performed, and comparisons were made using Fisher’s exact test, Chi-square and Wilcoxon rank-sum test. 

Results: The SLE patients exhibited low disease activity, with a mean Systemic Lupus Erythematosus Disease Activity Index-2K score of 4, but they experienced significantly more postoperative anemia than OA patients, and were seen in the emergency department more often in the 24 weeks postoperatively (Table 1).

The IFN module identified on weighted correlation network analysis was significantly elevated in SLE patients at all time points. The IFN module expression fell in both groups on POD1, while at 6W, the IFN activity returned to levels comparable to baseline in OA, but was significantly higher than baseline in SLE. A B cell module was also identified, and was significantly lower in SLE patients versus OA controls at all time points. Lower B cell module expression (including FCRL2, PAX5, and CD22) was also associated with postoperative anemia, though immunoglobulin transcripts and IFN module expression were higher in this same group (Figure 1). Patients undergoing THA or TKA for avascular necrosis were noted to have high baseline expression of IFN-inducible transcripts, immunoglobulin transcripts, and cell cycle-associated transcripts, though they did not demonstrate specific reduction in B cell module expression (Figure 2).

Conclusion: This prospective analysis reveals dynamic changes in disease-associated transcripts, including B cell and IFN modules, in SLE patients post-THA/TKA, with distinct expression patterns linked to anemia and avascular necrosis. This the first prospective analysis of SLE patients undergoing THA/TKA, proving the feasibility of such studies and larger prospective studies may allow for better assessment of factors associated with adverse events in SLE patients after THA/TKA.

Supporting image 1

Table 1. Demographic and Clinical Characteristics of the Cohort

Supporting image 2

Figure 1. Volcano plot depicting differentially expressed genes (DEGs) associated with acute blood loss anemia in lupus patients undergoing THA or TKA, and pathway analysis of the significant DEGs.

Supporting image 3

Figure 2. Volcano plot depicting differentially expressed genes (DEGs) associated with avascular necrosis in lupus patients undergoing THA or TKA, and pathway analysis of the significant DEGs.


Disclosures: D. Fernandez: None; S. Batter: None; D. Jannat-Khah: AstraZeneca, 11, Cytodyn, 11; M. Olferiev: None; I. Mannstadt: None; M. Figgie: HS2, 11, Icarus, 11, Joint Effort ASO, 11, Lima, 2, 9, Mekanika, 11, Wishbone, 2, 4, 10; P. Sculco: BetterPT, 8, EOS Imaging, 2, HS2, LLC, 8, HSS ASC Development Network, LLC, 8, Interllijoint Surgical, Inc., 2, 5, 8, Joint Effort Administrative Services Organization, 8, Lima Corporate, 2, 9, Osgenic, 1, 8, Parvizi Surgical Innovation, LLC, 8, Tangen Biosciences, Inc., 8, ZIMMER BIOMET, 2, 5; J. Blevins: Globus Medical, 2, Lima Corporate, 2, Smith and Nephew, 2; C. Siegel: None; D. Greenman: None; K. Kirou: None; S. Goodman: Novartis Corporation Pharmaceuticals, 5, UCB, 1.

To cite this abstract in AMA style:

Fernandez D, Batter S, Jannat-Khah D, Olferiev M, Mannstadt I, Figgie M, Sculco P, Blevins J, Siegel C, Greenman D, Kirou K, Goodman S. Systemic Lupus Erythematosus Patients Exhibit Dynamic Changes in Disease-Associated Transcripts Following Total Knee or Total Hip Arthroplasty [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/systemic-lupus-erythematosus-patients-exhibit-dynamic-changes-in-disease-associated-transcripts-following-total-knee-or-total-hip-arthroplasty/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/systemic-lupus-erythematosus-patients-exhibit-dynamic-changes-in-disease-associated-transcripts-following-total-knee-or-total-hip-arthroplasty/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology